- Home
- WASH vs KROS Comparison
WASH vs KROS Comparison
Compare WASH & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- KROS
- Stock Information
- Founded
- WASH 1800
- KROS 2015
- Country
- WASH United States
- KROS United States
- Employees
- WASH N/A
- KROS N/A
- Industry
- WASH Major Banks
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- KROS Health Care
- Exchange
- WASH Nasdaq
- KROS Nasdaq
- Market Cap
- WASH 623.4M
- KROS 460.6M
- IPO Year
- WASH N/A
- KROS 2020
- Fundamental
- Price
- WASH $32.52
- KROS $11.00
- Analyst Decision
- WASH Hold
- KROS Buy
- Analyst Count
- WASH 2
- KROS 11
- Target Price
- WASH $34.00
- KROS $45.33
- AVG Volume (30 Days)
- WASH 205.0K
- KROS 2.1M
- Earning Date
- WASH 01-29-2025
- KROS 02-26-2025
- Dividend Yield
- WASH 6.78%
- KROS N/A
- EPS Growth
- WASH N/A
- KROS N/A
- EPS
- WASH N/A
- KROS N/A
- Revenue
- WASH $98,251,000.00
- KROS $651,000.00
- Revenue This Year
- WASH N/A
- KROS $303.27
- Revenue Next Year
- WASH $10.09
- KROS N/A
- P/E Ratio
- WASH N/A
- KROS N/A
- Revenue Growth
- WASH N/A
- KROS 8037.50
- 52 Week Low
- WASH $24.11
- KROS $9.78
- 52 Week High
- WASH $40.59
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- WASH 48.04
- KROS 24.79
- Support Level
- WASH $30.79
- KROS $11.04
- Resistance Level
- WASH $32.89
- KROS $11.99
- Average True Range (ATR)
- WASH 0.99
- KROS 0.60
- MACD
- WASH 0.19
- KROS 1.20
- Stochastic Oscillator
- WASH 57.22
- KROS 43.99
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.